Amira Jamoussi
Medical Intensive Care Unit, Abderrahmen Mami Hospital, Ariana 2080, Tunisia; University of Tunis El Manar, Faculty of Medicine of Tunis, Tunis 1007, Tunisia
Takoua Merhabene
Medical Intensive Care Unit, Abderrahmen Mami Hospital, Ariana 2080, Tunisia; University of Tunis El Manar, Faculty of Medicine of Tunis, Tunis 1007, Tunisia
Mona Mlika
University of Tunis El Manar, Faculty of Medicine of Tunis, Tunis 1007, Tunisia; Anatomopathology, Abderrahmen Mami hospital, Ariana 2080, Tunisia
Henda Neji
University of Tunis El Manar, Faculty of Medicine of Tunis, Tunis 1007, Tunisia; Medical Imaging, Abderrahmen Mami Hospital, Ariana 2080, Tunisia
Faouzi El Mezni
University of Tunis El Manar, Faculty of Medicine of Tunis, Tunis 1007, Tunisia; Anatomopathology, Abderrahmen Mami hospital, Ariana 2080, Tunisia
Jalila Ben Khelil
Medical Intensive Care Unit, Abderrahmen Mami Hospital, Ariana 2080, Tunisia; University of Tunis El Manar, Faculty of Medicine of Tunis, Tunis 1007, Tunisia
Mohamed Besbes
Medical Intensive Care Unit, Abderrahmen Mami Hospital, Ariana 2080, Tunisia; University of Tunis El Manar, Faculty of Medicine of Tunis, Tunis 1007, Tunisia
Abstract
Chronic beryllium disease (CBD) is an occupational illness with varying severity. In this report, we describe a 27 year old man, glassblower, who developed a fatal CBD after six months of unknown Beryllium's exposure. The diagnosis was suspected on histological examination and then consolidated by confirmation of Beryllium's exposure at the working area. Physicians should be aware of the potential risk to develop CBD in glassblowers. These workers should benefit from early medical surveillance using the Beryllium lymphocyte proliferation test (BeLPT) and therefore from suitable management.